Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4951
CALL
PENN Entertainment
PENN
$2.37B
| $4.27M | ﹤0.01% |
199,900
-7,200
| -3% | -$129K |
|
4952
CALL
nLIGHT
LASR
$2.25B
| $4.27M | ﹤0.01% |
61,300
-50,100
| -45% | -$3.5M |
|
4953
CALL
Kodiak Sciences
KOD
$2.07B
| $4.27M | ﹤0.01% |
109,500
+31,900
| +41% | +$1.24M |
|
4954
CALL
BCE
BCE
$21.1B
| $4.26M | ﹤0.01% |
198,100
-36,900
| -16% | -$885K |
|
4955
PennyMac Financial
PFSI
$3.48B
| $4.26M | ﹤0.01% |
48,903
-1,109,245
| -96% | -$96.5M |
|
4956
ARS Pharmaceuticals
SPRY
$415M
| $4.25M | ﹤0.01% |
531,063
-1,242,125
| -70% | -$10.7M |
|
4957
CALL
Saia
SAIA
$9.21B
| $4.25M | ﹤0.01% |
10,100
-8,300
| -45% | -$3.65M |
|
4958
PUT
LPL Financial
LPLA
$26.1B
| $4.25M | ﹤0.01% |
15,100
-11,700
| -44% | -$3.51M |
|
4959
PUT
Invesco PHLX Semiconductor ETF
SOXQ
$2.94B
| $4.25M | ﹤0.01% |
37,900
+25,600
| +208% | +$2.32M |
|
4960
Worthington Steel
WS
$1.72B
| $4.25M | ﹤0.01% |
126,462
+81,576
| +182% | +$3.13M |
|
|
HSAI
4961
CALL
Hesai Group
HSAI
$2.7B
| $4.25M | ﹤0.01% |
233,000
+144,200
| +162% | +$2.95M |
|
4962
CALL
Intellia Therapeutics
NTLA
$1.77B
| $4.24M | ﹤0.01% |
250,500
+1,700
| +0.7% | +$23.8K |
|
4963
Keros Therapeutics
KROS
$218M
| $4.24M | ﹤0.01% |
396,098
-10,568
| -3% | -$118K |
|
4964
PUT
JFrog
FROG
$11.8B
| $4.24M | ﹤0.01% |
46,600
+24,700
| +113% | +$1.6M |
|
4965
Shore Bancshares
SHBI
$778M
| $4.23M | ﹤0.01% |
184,514
+153,417
| +493% | +$3.12M |
|
|
METU
4966
CALL
Direxion Daily META Bull 2X ETF
METU
$527M
| $4.23M | ﹤0.01% |
209,100
-137,000
| -40% | -$3.41M |
|
4967
WisdomTree
WT
$3.38B
| $4.23M | ﹤0.01% |
+249,893
| New | +$4.42M |
|
4968
PUT
Dianthus Therapeutics
DNTH
$5.7B
| $4.23M | ﹤0.01% |
43,400
+11,600
| +36% | +$1.01M |
|
|
ETHU
4969
CALL
2x Ether ETF
ETHU
$1.19B
| $4.23M | ﹤0.01% |
370,780
+53,090
| +17% | +$1.12M |
|
4970
PUT
Lantheus
LNTH
$6.59B
| $4.23M | ﹤0.01% |
38,100
-49,400
| -56% | -$4.6M |
|
4971
CALL
STAAR Surgical
STAA
$1.1B
| $4.23M | ﹤0.01% |
147,300
+1,400
| +1% | +$38.9K |
|
4972
CALL
Photronics
PLAB
$1.68B
| $4.23M | ﹤0.01% |
129,900
+50,900
| +64% | +$2.15M |
|
4973
PUT
Antero Midstream
AM
$10.1B
| $4.22M | ﹤0.01% |
185,700
+9,300
| +5% | +$202K |
|
4974
Franklin Electric
FELE
$4.25B
| $4.22M | ﹤0.01% |
39,404
-41,562
| -51% | -$4.17M |
|
4975
Cimpress
CMPR
$2B
| $4.22M | ﹤0.01% |
41,517
+15,515
| +60% | +$1.38M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.